Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy

NCT00895310 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Ketoconazole
DRUG: Hydrocortisone

Sponsor

University of California, Davis